Skip to main content

Table 2 Associations between various DXA-based fat depots and incident atrial fibrillation

From: Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study

DXA-based (N = 3468) Hazard ratio (95% confidence interval)
Model 1 Model 2 Model 3a Model 4b
Total fat mass 1.28 (1.15–1.42) 1.22 (1.09–1.36) 1.17 (1.04–1.32)
 Fat mass percentage 1.22 (1.07–1.41) 1.19 (1.03–1.37)
Android fat mass 1.20 (1.09-1.32) 1.14 (1.03–1.27) 1.06 (0.94–1.19) 0.78 (0.60–1.02)
 Android fat percentage 1.09 (0.99–1.21) 1.06 (0.95–1.18) 1.04 (0.93–1.16)
Gynoid fat mass 1.31 (1.18–1.46) 1.26 (1.13–1.41) 1.21 (1.08–1.37) 1.36 (0.96–1.93)
 Gynoid fat percentage 1.28 (1.09–1.49) 1.25 (1.07–1.47) 1.28 (1.09–1.50)
Android-to-gynoid
fat ratio
0.93 (0.81–1.06) 0.85 (0.74–0.98) 0.84 (0.72–0.97) 0.82 (0.70–0.95)
  1. Values are shown as hazard ratios and 95% confidence interval per 1 standard deviation increase of corresponding fat depots
  2. Abbreviations DXA Dual-energy X-ray absorptiometry
  3. Model 1 was adjusted for sex and age
  4. Model 2 was additionally adjusted for high-density lipoprotein cholesterol, total cholesterol, smoking, total alcohol intake, lipid-lowering medication and cardiac medication and history of hypertension, left ventricular hypertrophy, diabetes mellitus, heart failure, and coronary heart disease
  5. aModel 3: Model 2 + total lean mass
  6. bModel 4: Model 2 + total fat mass